Clostridium perfringens epsilon toxin (ETX)

Clostridium perfringens epsilon toxin (ETX) is a highly potent pore-forming protein produced by C. perfringens types B and D, recognized as one of the most lethal bacterial toxins (Knapp et al., 2016, Toxins). It is secreted as an inactive prototoxin that requires proteolytic cleavage by host enzymes like trypsin to reach its mature, active form (Popoff, 2011, Toxicon). ETX specifically targets cells expressing the Myelin and Lymphocyte (MAL) protein, which acts as its primary receptor, allowing the toxin to bind and form heptameric pores in the membranes of endothelial cells and oligodendrocytes (Rumah et al., 2013, PLoS ONE). This pore formation leads to rapid cell death, blood-brain barrier disruption, and severe neurological edema, primarily causing enterotoxemia in livestock (Linden et al., 2015, Journal of Neuroinflammation). In humans, ETX is of significant interest due to its hypothesized role in the pathogenesis of Multiple Sclerosis, as it can selectively damage the myelin sheath and brain vasculature (Wagley et al., 2019, Scientific Reports). Current therapeutic development focuses on neutralizing monoclonal antibodies and toxoid vaccines to prevent the toxin's lethal effects and potential contribution to autoimmune neurodegeneration (Garcia et al., 2020, Toxins).

Other names

Epsilon toxinETXClostridium perfringens type B/D toxinAerolysin-like toxin ETX

Neutralization of toxin activity by preventing binding to the MAL receptor or inhibiting the oligomerization and pore-formation process in host cell membranes.